Results

Total Results: 188 records

Showing results for "hepatitis c".
Users also searched for: hepatitis c

101. Prevention, Diagnosis, and Management of Opioids, Opioid Misuse and Opioid Use Disorder in Older Adults: Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioids-oa-protocol.pdf
     June 29, 2019 - c. … Han B, Compton WM, Blanco C, Crane E, et al. … Grashorn W, Sprenger C, Forkmann K, Wrobel N, et al. … Kearney PM, Baigent C, Godwin J, Halls H, et al. … Siokou C, Morgan R, Shiell A.

102. Breast-Cancer-Imaging Technical-Brief (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_technical-brief.pdf
     October 01, 2014 - Summary of Key Informant Interviews Appendix C. … Lin NU, Thomssen C, Cardoso F, et al. … Huyge V, Garcia C, Alexiou J, et al. … Tateishi U, Gamez C, Dawood S, et al. … Podoloff D, Advani R, Allred C, et al.

103. Research Review Title: Infection Prevention and Control for the Emergency Medical Services and 911 Workforce (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ems-911-workforce-disposition-comments.pdf
     November 01, 2022 - describe organisms of interest and explicitly named “MRSA, SARS-CoV2, influenza, tuberculosis, HIV, and hepatitis … B and C”, enteric pathogens like norovirus should also be included. … The demographics of the study populations are presented in Evidence Table C-2. … exposure and effectiveness of workforce practices regarding influenza (including H1N1), MRSA, and hepatitis … C.

104. Cancer-Pancreas Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-pancreas_executive.pdf
     September 01, 2014 - c. … c. … c. … c. … c.

105. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
     June 16, 2010 - B, 1:30,000 to 1:150,000 for Hepatitis C and 1:250,000 to 1:1,000,000 for HIV.26 Emerging infections … C. … Leitgeb C, Pecherstorfer M, Fritz E, et al. … Henke M, Laszig R, Rübe C, et al. … Bohlius J, Schmidlin K, Brillant C, et al.

106. Executive Summary: Systematic Review_Implementing Recommended Mental Health and Substance Use Screening and Counseling Interventions in Primary Care Settings for Children and Adolescents (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/screening-counseling-interventions-executive-summary.pdf
     April 01, 2025 - Centers For Disease Control and Prevention, National Center for HIV, Viral Hepatitis, StD, And TB Prevention … Richardson LP, Zhou C, Gersh E, et al. … Richardson L, Parker EO, Zhou C, et al. … Beck KE, Snyder D, Toth C, et al. … Report Gartlehner G, Patel SV, Hart L, Rotunda W, Kugley S, Schwimmer M, Pilar M, Booth G, Voisin C,

107. Draft Comparative Effectiveness Review Appendicies (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_appendixes.pdf
     April 01, 2005 - Ann Surg 201(2):219-2. 1985 N<100 (Surgery study) C-1 Appendix C. … C. … J Hypertens Suppl 1(2):123-5. 1983 Single dose C-13 Appendix C. … Cardiovasc Intervent Radiol 17(3):143-6. 1994 C-15 Appendix C. … 15 16 [1.4] 87-96 C L Marone.2004 96 12 23 22 90-01 C L Cherr.2002 500 13 23 21 [2.6] 87-99 C L Harden

108. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-insulin_executive.pdf
     September 01, 2008 - c. Intermediate-acting human insulin (NPH insulin) administered alone. d. … c. Individuals with comorbid medical conditions. d. Individuals with limited life expectancy. e.

109. Disposition of Comments Report for Biologic and Nonbiologic Systemic Agents and Phottherapy for Treatment of Chronic Plaque Psoriasis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_disposition-comments.pdf
     November 27, 2012 - Discussion/C onclusion Yes but some minor points are already partly answered in the RCT on Briakinumab … severe psoriasis.Griffiths CE, Strober BE, van de Kerkhof P, Ho V, Fidelus- Gort R, Yeilding N, Guzzo C, … Discussion/C onclusion As mentioned above, don’t say “complete remission;” instead, say “complete … Discussion/C onclusion The discussion and conclusion provide a good summary of the available evidence

110. Computerized Definitions Showed High Positive Predictive Values for Identifying Reasons for Hospitalizations in a Medicaid Population with Rheumatoid Arthritis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-hospitalizations_research.pdf
     October 01, 2008 - Chung, M.D., M.P.H.2 C. Michael Stein, M.D.2 Patricia S. Gideon, R.N.1 Shannon M. … Curtis JR, Patkar N, Xie A, Martin C, Allison JJ, Saag M, et al. … Curtis JR, Martin C, Saag KG, Patkar NM, Kramer J, Shatin D, et al.

111. Dietary-Supplements Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
     January 01, 2013 - Pooled analyses for levels of HDL-C (seven trials), LDL-C (six trials), and total cholesterol (six … Evidence was inconclusive for the outcomes of total cholesterol/HDL-C ratio, non-HDL-C, lipoprotein … LDL-C, total cholesterol, triglycerides, non-HDL-C) in 52 obese men with dyslipidemia and insulin … Evidence was inconclusive for the outcomes of total cholesterol/HDL-C ratio, non-HDL-C, lipoprotein … LDL-C, total cholesterol, triglycerides, non-HDL-C) in 52 obese men with dyslipidemia and insulin

112. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
     March 10, 2010 - LDL-C remains ? 190 mg/dL or 2. LDL-C remains ? 160 mg/dL and ? … , indirect LDL-c data were considered valid estimation of true LDL-c (adequate fasting). … to decrease LDL-C. … According to table 5, LDL-c goal of < 100 mg/dL as per ADA also happens to be the same at ATP III LDL-c … Appendix C C-1, C-2, C-3, C-4, C-7, C-8, Durrington (2004) should be as follows: Rosuvastatin 40,

113. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/screening-counseling-interventions-protocol-amendment.pdf
     February 05, 2025 - C. … Global Burden of Disease Pediatrics C, Kyu HH, Pinho C, et al. … Centers for Disease Control and Prevention, National Center for HIV, Viral Hepatitis, STD, and TB … Guise JM, Butler ME, Chang C, et al.

114. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stroke-atrial-fibrillation_research-protocol.pdf
     January 30, 2012 - C. … Hylek EM, Evans-Molina C, Shea C, et al.

115. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - HHSA290-2010-00006-C Prepared by: ECRI Institute 5200 Butler Pike Plymouth Meeting, PA 19462 … HHSA290-2010-00006-C). … HHSA290-2010-00006-C.) Rockville, MD: Agency for Healthcare Research and Quality. … Gaffey C. 'Pill on a string' could speed up cancer diagnoses and save thousands of lives. … Rudy SF, Adams J, Waddington C.

116. Implementation of Recommended Screening and Counseling Interventions to Prevent Mental Health Disorders in Children and Adolescents (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/screening-counseling-interventions-protocol.pdf
     October 01, 2023 - C. … Global Burden of Disease Pediatrics C, Kyu HH, Pinho C, et al. … Centers for Disease Control and Prevention, National Center for HIV, Viral Hepatitis, STD, and TB … Guise JM, Butler ME, Chang C, et al.

117. Nonopioid Pharmacologic Treatments for Chronic Pain: Appendix E (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-ape_0.xlsx
     August 08, 2017 - Duloxetine 60 mg/day (n=86) C. … Milnacipran 150 mg/day (n=92) C. … Milnacipran 100 mg/day (n=29) C. … Oral diclofenac C. … Desvenlafaxine C. Duloxetine D.

118. Cancer-Drugs-Utilization-Cost Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization-cost_research.pdf
     January 01, 2011 - In 2006, cancer care represented 1 in 10 Medicare fee-for-service (FFS) payments (excluding Part C … #9.7 Although the Food and Drug Administration (FDA) has labeled peginterferon alfa-2a for use in hepatitis … CWF to extract all Parts A and B claims containing HCPCS or CPT codes for biologics of interest; (c) … c=69641&p=irol-newsArticle&ID=989907&highlight=. Accessed: September 14, 2010. … c=69641&p=irol-newsArticle&ID=989907&highlight=

119. Disposition of Comments Report for Imaging Techniques for the Diagnosis and Staging of Hepatocellular Carcinoma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer_disposition-comments.pdf
     October 23, 2014 - Research Review Citation: Chou R, Cuevas C, Fu R, Devine B, Wasson N, Ginsburg A, Zakher B, Pappas M … the Zhang, et al randomized trial of ultrasound vs. no screening for HCC is the population had more hepatitis … Hepatitis B patients develop HCC in the absence of cirrhosis and would be more likely to be resection … manuscript which includes the same Figures as the executive summary- Figure A p15, Figure B p 16, Figure C … evidence on clinical outcomes associated with imaging for screening is presented in the report (see KQ1.c)

120. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/angina-heart-attack-treatments_research-protocol.pdf
     December 11, 2012 - c. … c. … c. … C.